Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma

BACKGROUND: The 2-week schedule of hypofractionated radiotherapy as a salvage treatment for hepatocellular carcinoma (HCC) has previously exhibited promising results; this study aimed to assess its long-term clinical outcomes in patients with recurrent HCC ineligible for curative treatments. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jongmoo, Jung, Jinhong, Kim, Daegeun, Jung, In-Hye, Park, Jin-hong, Kim, Jong Hoon, Lee, Sang-wook, Yoon, Sang Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203968/
https://www.ncbi.nlm.nih.gov/pubmed/30367606
http://dx.doi.org/10.1186/s12885-018-4953-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203968/
https://www.ncbi.nlm.nih.gov/pubmed/30367606
http://dx.doi.org/10.1186/s12885-018-4953-x

Ejemplares similares